Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin Prophylaxis in RIRS
NCT02304822Unknown
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ciprofloxacin in Systemic Inflammatory Response Syndrome (SIRS) (3 arms). Primary endpoint: Postoperative Systemic Inflammatory Response Syndrome at 4 weeks. Status: unknown.
02
Drugs
ciprofloxacin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02304822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304822.